remedent: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
remedent
NACE 32.500, Manufacture of medical and dental instruments and supplies
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€385,552
2024 · -€260,324-€125,228
Equity
€2.3m
2024 · €2.6m-€385,552
Cash
€3,780
2024 · €4,775-€996
Balance sheet total
€4.0m
2024 · €4.5m-€432,330
Largest movements
Assets
- Financial fixed assets -€262,440
down €262,440 (-14.9%), from €1.8m to €1.5m
of which Companies linked by participating interests: -€262,440
- Receivables within one year -€163,694
down €163,694 (-6.3%), from €2.6m to €2.4m
of which Trade receivables: -€231,439
Equity and liabilities
- Profit (loss) carried forward -€385,552
down €385,552, from €302,890 to -€82,662
- Trade debts -€307,953
down €307,953 (-20.6%), from €1.5m to €1.2m
- Other debts +€157,254
up €157,254 (+521%), from €30,160 to €187,413
- Tax, wage and social debts +€126,706
up €126,706 (+52.0%), from €243,587 to €370,293
of which Taxes: +€113,639
Income statement
- Financial charges +€161,102
up €161,102 (+125%), from €128,722 to €289,825
of which Non-recurring financial charges: +€159,860
- Other operating income -€119,443
down €119,443 (-30.3%), from €393,660 to €274,216
- Services and other goods -€109,539
down €109,539 (-65.1%), from €168,188 to €58,649
- Staff costs -€43,290
down €43,290 (-11.4%), from €378,358 to €335,069
- Goods and materials -€11,560
down €11,560 (-41.5%), from €27,864 to €16,305
of which Purchases: -€11,729
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
-€260,324
Turnover
-€7,661
Other operating income
-€119,443
Goods and materials
+€11,560
Services and other goods
+€109,539
Staff costs
+€43,290
Depreciation
+€2,171
Write-downs
+€7,697
Other operating charges
-€8,378
Financial income
-€2,472
Financial charges
-€161,102
Taxes
-€429
Result 2025
-€385,552
raises the resultlowers the result
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
-€255,202
Investment
+€254,207
Financing
€0
Cash 2024
€4,775
From operations (derived)
-€255,202
Net result for the year
-€385,552
Depreciation
+€13,879
Stocks and contracts
-€966
Receivables within one year
+€163,694
Deferred charges and accrued income
+€521
Trade debts
-€307,953
Tax, wage and social debts
+€126,706
Other debts
+€157,254
Accrued charges and deferred income
-€22,784
Investment (derived)
+€254,207
Investment in fixed assets (net)
+€254,207
Cash 2025
€3,780
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €4,468,660 | €4,036,331 | -€432,330 | -9.7% |
| Fixed assets | 21/28 | €1,780,455 | €1,512,369 | -€268,086 | -15.1% |
| Intangible fixed assets | 21 | €9,500 | €3,500 | -€6,000 | -63.2% |
| Tangible fixed assets | 22/27 | €6,644 | €6,998 | +€354 | +5.3% |
| Plant, machinery and equipment | 23 | €5,796 | €4,061 | -€1,735 | -29.9% |
| Furniture and vehicles | 24 | €848 | €2,936 | +€2,088 | +246% |
| Financial fixed assets | 28 | €1,764,312 | €1,501,872 | -€262,440 | -14.9% |
| Affiliated companies | 280/1 | €30,750 | €30,750 | = | 0.0% |
| Participating interests | 280 | €30,750 | €30,750 | = | 0.0% |
| Companies linked by participating interests | 282/3 | €1,616,198 | €1,353,758 | -€262,440 | -16.2% |
| Participating interests | 282 | €1,616,198 | €1,353,758 | -€262,440 | -16.2% |
| Other financial fixed assets | 284/8 | €117,364 | €117,364 | = | 0.0% |
| Shares | 284 | €117,364 | €117,364 | = | 0.0% |
| Current assets | 29/58 | €2,688,205 | €2,523,962 | -€164,244 | -6.1% |
| Stocks and contracts in progress | 3 | €85,647 | €86,613 | +€966 | +1.1% |
| Stocks | 30/36 | €85,647 | €86,613 | +€966 | +1.1% |
| Goods purchased for resale | 34 | €85,647 | €86,613 | +€966 | +1.1% |
| Amounts receivable within one year | 40/41 | €2,594,873 | €2,431,180 | -€163,694 | -6.3% |
| Trade receivables | 40 | €2,549,873 | €2,318,434 | -€231,439 | -9.1% |
| Other amounts receivable | 41 | €45,000 | €112,745 | +€67,745 | +151% |
| Cash at bank and in hand | 54/58 | €4,775 | €3,780 | -€996 | -20.8% |
| Deferred charges and accrued income | 490/1 | €2,910 | €2,389 | -€521 | -17.9% |
| Total equity and liabilities | 10/49 | €4,468,660 | €4,036,331 | -€432,330 | -9.7% |
| Equity | 10/15 | €2,641,605 | €2,256,053 | -€385,552 | -14.6% |
| Contributions | 10/11 | €2,210,000 | €2,210,000 | = | 0.0% |
| Capital | 10 | €2,210,000 | €2,210,000 | = | 0.0% |
| Issued capital | 100 | €2,210,000 | €2,210,000 | = | 0.0% |
| Reserves | 13 | €128,715 | €128,715 | = | 0.0% |
| Non-distributable reserves | 130/1 | €128,715 | €128,715 | = | 0.0% |
| Legal reserve | 130 | €128,715 | €128,715 | = | 0.0% |
| Profit (loss) carried forward | 14 | €302,890 | -€82,662 | -€385,552 | |
| Amounts payable | 17/49 | €1,827,055 | €1,780,278 | -€46,777 | -2.6% |
| Amounts payable within one year | 42/48 | €1,771,748 | €1,747,754 | -€23,994 | -1.4% |
| Trade debts | 44 | €1,498,001 | €1,190,048 | -€307,953 | -20.6% |
| Suppliers | 440/4 | €1,498,001 | €1,190,048 | -€307,953 | -20.6% |
| Taxes, remuneration and social security | 45 | €243,587 | €370,293 | +€126,706 | +52.0% |
| Taxes | 450/3 | €89,179 | €202,818 | +€113,639 | +127% |
| Remuneration and social security | 454/9 | €154,408 | €167,475 | +€13,067 | +8.5% |
| Other amounts payable | 47/48 | €30,160 | €187,413 | +€157,254 | +521% |
| Accrued charges and deferred income | 492/3 | €55,307 | €32,524 | -€22,784 | -41.2% |
| Operating income | 70/76A | €463,488 | €336,385 | -€127,104 | -27.4% |
| Turnover | 70 | €69,829 | €62,168 | -€7,661 | -11.0% |
| Other operating income | 74 | €393,660 | €274,216 | -€119,443 | -30.3% |
| Operating charges | 60/66A | €598,886 | €433,007 | -€165,879 | -27.7% |
| Goods for resale, raw materials and consumables | 60 | €27,864 | €16,305 | -€11,560 | -41.5% |
| Purchases | 600/8 | €29,000 | €17,271 | -€11,729 | -40.4% |
| Change in stocks: decrease (increase) | 609 | -€1,135 | -€966 | +€169 | +14.9% |
| Services and other goods | 61 | €168,188 | €58,649 | -€109,539 | -65.1% |
| Remuneration, social security and pensions | 62 | €378,358 | €335,069 | -€43,290 | -11.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €16,050 | €13,879 | -€2,171 | -13.5% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €7,697 | - | -€7,697 | |
| Other operating charges | 640/8 | €729 | €9,106 | +€8,378 | +1,150% |
| Operating profit (loss) | 9901 | -€135,398 | -€96,622 | +€38,775 | +28.6% |
| Financial income | 75/76B | €4,315 | €1,843 | -€2,472 | -57.3% |
| Recurring financial income | 75 | €4,315 | €1,843 | -€2,472 | -57.3% |
| Other financial income | 752/9 | €4,315 | €1,843 | -€2,472 | -57.3% |
| Financial charges | 65/66B | €128,722 | €289,825 | +€161,102 | +125% |
| Recurring financial charges | 65 | €26,142 | €27,385 | +€1,243 | +4.8% |
| Debt charges | 650 | €1,872 | €1,551 | -€321 | -17.2% |
| Other financial charges | 652/9 | €24,270 | €25,834 | +€1,564 | +6.4% |
| Non-recurring financial charges | 66B | €102,580 | €262,440 | +€159,860 | +156% |
| Profit (loss) for the period before taxes | 9903 | -€259,805 | -€384,604 | -€124,799 | -48.0% |
| Income taxes | 67/77 | €519 | €948 | +€429 | +82.6% |
| Taxes | 670/3 | €519 | €948 | +€429 | +82.6% |
| Profit (loss) for the period | 9904 | -€260,324 | -€385,552 | -€125,228 | -48.1% |
| Profit (loss) for the period to be appropriated | 9905 | -€260,324 | -€385,552 | -€125,228 | -48.1% |
Source: filed annual accounts (NBB), financial years ended 31 March 2024 and 31 March 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 23 October 2026 via checked.be.